Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.73 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.73 |
| ▸ | TSHR | P16473 | 1/20 | 0.73 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.73 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.67 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.67 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.60 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.60 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.60 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.60 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.60 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.60 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.60 |
| ▸ | BLM | P54132 | 1/20 | 0.60 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.60 |
| ▸ | POLB | P06746 | 1/20 | 0.59 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.59 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.58 |
| ▸ | CASP1 | P29466 | 1/20 | 0.58 |
| ▸ | CASP7 | P55210 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL8547494 | 0.99 | ALDH1A1 (0.71) | ALDH1A1CYP2C19TSHRSMN1; SMN2PABPC1 | |
| SCHEMBL13609261 | 0.89 | PABPC1 (0.73) | ALDH1A1CYP2C19TSHRSMN1; SMN2PABPC1 | |
| SCHEMBL16029332 | 0.88 | ALDH1A1 (0.71) | ALDH1A1CYP2C19TSHRSMN1; SMN2PABPC1 | |
| SCHEMBL4613444 | 0.86 | RXFP1 (0.67) | ALDH1A1CYP2C19TSHRSMN1; SMN2PABPC1 | |
| SCHEMBL13609275 | 0.86 | RXFP1 (0.60) | ALDH1A1CYP2C19TSHRSMN1; SMN2PABPC1 | |
| SCHEMBL16029379 | 0.85 | ALDH1A1 (0.58) | ALDH1A1CYP2C19TSHRSMN1; SMN2PABPC1 | |
| SCHEMBL8620381 | 0.85 | ALDH1A1 (0.58) | ALDH1A1CYP2C19TSHRSMN1; SMN2PABPC1 | |
| SCHEMBL10350972 | 0.84 | RXFP1 (0.65) | ALDH1A1CYP2C19TSHRSMN1; SMN2PABPC1 | |
| SCHEMBL22521838 | 0.84 | RXFP1 (0.65) | ALDH1A1CYP2C19TSHRSMN1; SMN2PABPC1 | |
| SCHEMBL4226426 | 0.84 | ALDH1A1 (1.00) | ALDH1A1CYP2C19TSHRSMN1; SMN2PABPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 69 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117919253-A | Application of xanthine compound in preparation of medicines for activating primordial follicles | 华南理工大学 | 2024-04-26 | — | — | CN | claimed |
| EP-0680479-B1 | METHOD FOR PREPARING BAMIFYLLINE AND ETAMIPHYLLINE | NYCOMED CHRISTIAENS NV SA (BE) | 1999-03-17 | — | — | EP | claimed |
| US-5739331-A | PREPARING BAMIFYLLINE AND ETAMIPHYLLINE | S.A. NYCOMED CHRISTIAENS N.V. (BE) | 1998-04-14 | — | — | US | claimed |
| EP-0680479-A1 | METHOD FOR CONVERTING A XANTHINE RING OR DERIVATIVES THEREOF INTO DIALKYLAMINO-XANTHINE DERIVATIVES | S.A. NYCOMED CHRISTIAENS N.V. (BE) | 1995-11-08 | — | — | EP | claimed |
| WO-1994017064-A1 | METHOD FOR CONVERTING A XANTHINE RING OR DERIVATIVES THEREOF INTO DIALKYLAMINO-XANTHINE DERIVATIVES | S.A. NYCOMED CHRISTIAENS N.V. (BE) | 1994-08-04 | — | — | WO | claimed |
| US-20250386846-A1 | Food Compositions Including Aragonite | NANT HOLDINGS IP LLC (US) | 2025-12-25 | — | — | US | disclosed |
| US-12419336-B2 | Beverage compositions including calcium supplied from aragonite and methods of making the same | NANT HOLDINGS IP, LLC (US) | 2025-09-23 | — | — | US | disclosed |
| US-20250194654-A1 | Beverage Compositions Including Calcium Supplied From Aragonite And Methods Of Making The Same | NANT HOLDINGS IP, LLC | 2025-06-19 | — | — | US | disclosed |
| US-12310392-B2 | Beverage compositions including calcium supplied from aragonite and methods of making the same | NANT HOLDINGS IP, LLC (US) | 2025-05-27 | — | — | US | disclosed |
| US-20240381918-A1 | Beverage Compositions Including Calcium Supplied From Aragonite And Methods Of Making The Same | NANT HOLDINGS IP, LLC | 2024-11-21 | — | — | US | disclosed |
| US-12089621-B2 | Beverage compositions including calcium supplied from aragonite and methods of making the same | NANT HOLDINGS IP, LLC (US) | 2024-09-17 | — | — | US | disclosed |
| CN-117919253-A | Application of xanthine compound in preparation of medicines for activating primordial follicles | 华南理工大学 | 2024-04-26 | — | — | CN | disclosed |
| WO-2001005253-A1 | COMPOSITIONS, KITS, AND METHODS FOR PROVIDING AND MAINTAINING ENERGY AND MENTAL ALERTNESS | THE PROCTER & GAMBLE COMPANY (US) | 2001-01-25 | — | — | WO | disclosed |
| EP-0680479-B1 | METHOD FOR PREPARING BAMIFYLLINE AND ETAMIPHYLLINE | NYCOMED CHRISTIAENS NV SA (BE) | 1999-03-17 | — | — | EP | disclosed |
| US-5739331-A | PREPARING BAMIFYLLINE AND ETAMIPHYLLINE | S.A. NYCOMED CHRISTIAENS N.V. (BE) | 1998-04-14 | — | — | US | disclosed |
| US-5739331-A | PREPARING BAMIFYLLINE AND ETAMIPHYLLINE | S.A. NYCOMED CHRISTIAENS N.V. (BE) | 1998-04-14 | — | — | US | disclosed |
| EP-0680479-A1 | METHOD FOR CONVERTING A XANTHINE RING OR DERIVATIVES THEREOF INTO DIALKYLAMINO-XANTHINE DERIVATIVES | S.A. NYCOMED CHRISTIAENS N.V. (BE) | 1995-11-08 | — | — | EP | disclosed |
| WO-1994017064-A1 | METHOD FOR CONVERTING A XANTHINE RING OR DERIVATIVES THEREOF INTO DIALKYLAMINO-XANTHINE DERIVATIVES | S.A. NYCOMED CHRISTIAENS N.V. (BE) | 1994-08-04 | — | — | WO | disclosed |
| US-4942143-A | Imidazothiadiazine derivatives, and their use as medicaments | HOECHST JAPAN LIMITED (JP) | 1990-07-17 | — | — | US | disclosed |
| EP-0286041-A1 | Imidazothiadiazine derivatives, a process for preparing the same and their use as medicaments | HOECHST JAPAN LIMITED (JP) | 1988-10-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250386846-A1 | Food Compositions Including Aragonite | PLCG2, PLCG1, PLCB3 | ALDH1A1 4338/4885CYP2C19 3485/4885TSHR 3501/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.